Medical and Pharmaceutical Chinese researchers reveal optical sensor for early lung cancer detection The group combined DNA nanostructures, quantum dots and CRISPR gene-editing tools with a light-based technique called second harmonic generation Joseph MortonFebruary 17, 2026
Medical and Pharmaceutical Krystal Biotech co-founder makes Forbes 250 innovators list News comes after the company attained RMAT designation from the FDA for its lung cancer drug Rowan DunneFebruary 11, 2026
Medical and Pharmaceutical Nearly four in ten global cancer cases are preventable, WHO analysis finds Researchers at the International Agency for Research on Cancer examined data from 185 countries to quantify preventable cancer risk Joseph MortonFebruary 4, 2026
Medical and Pharmaceutical Chinese authorities approve new lung cancer screening blood draw It has demonstrated exceptional early-stage detection capabilities Rowan DunneFebruary 3, 2026
Medical and Pharmaceutical Philadelphia hospital initiates research partnership with canine cancer detection specialist ‘SpotitEarly’ Fox Chase Cancer Center will be leading a multi-year clinical study assessing SpotitEarly's lung cancer test Rowan DunneFebruary 2, 2026
Medical and Pharmaceutical NHS lung cancer screening pilot combines power of AI software and robotic bronchoscopy Optellum's AI detects nodules and Intuitive Surgical's device performs a precision biopsy Rowan DunneJanuary 28, 2026
Medical and Pharmaceutical Leading oncology organizations condemn ‘misinformation’ about lung cancer screening dangers One widely cited study was apparently relying on data from Japanese atomic bomb survivors Rowan DunneJanuary 26, 2026
Medical and Pharmaceutical Bristol Myers Squibb teams up with Microsoft for AI-powered lung cancer detection Artificial intelligence has been transforming healthcare in many regards Rowan DunneJanuary 21, 2026
AI and Autonomy BioMark earns peer-reviewed validation for AI-driven lung cancer detection model BioMark’s accepted paper describes a predictive model built on metabolomic pathway data rather than single biomarkers Joseph MortonJanuary 21, 2026
Medical and Pharmaceutical Ireland’s new lung cancer screening initiative is already making an impact The pilot campaign launched in 2025 with €4.9 million in backing from the Irish Cancer Society Rowan DunneJanuary 19, 2026